Orange Book product · Generic (ANDA)
TASIMELTEON
TASIMELTEON
Generic (ANDA)ANDA 211654TE ABRX MSN
At a glance
Jan 12, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 12, 2023
3 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
TASIMELTEON
Strength
20MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 211654
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TASIMELTEON
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
